Agenda & Learning Objectives


Participants in this program will be able to:
  • Understand mucosal immunological research in IBD from an international and Canadian perspective
  • Consider translational models including organoid and the Gut on a chip IBD from an international and Canadian perspective
  • Discuss current research in the area of microbiome and IBD
  • Interpret molecular mechanisms of IBD from an international and Canadian perspective
Time
Title/Topic
Speakers/Facilitators
08:30 EST  Opening Remarks 
Welcome, program objectives		 CO-CHAIRS:  Heather Armstrong & Jean-Eric Ghia

(1) Mucosal Immunology Session Chair: Jean-Eric Ghia
08:40 EST

1.1 Plenary Presentation
International: Brain-Gut Axis

 Wouter de Jonge, The Netherlands
09:20 EST
1.2 Plenary Presentation
Canadian: Mucosal Immunology
 Deanna Santer, Winnipeg
09:40 EST 1.3 Plenary Presentation
Canadian: Mucosal Immunology		 Alberto Caminero, Hamilton
10:00 EST 1.4 Expert Panel Discussion/Q&A MODERATOR: Jean-Eric Ghia
PANEL: Alberto Caminero,  Wouter de Jonge, Deanna Santer
10:20 EST Refreshment and Network Break (15 mins)  

(2) Translational Models  Session Chair: Heather Armstrong
10:40 EST

2.1 Plenary Presentation
International: Translational Models

 Phillipe Langella, France
11:20 EST 2.2 Plenary Presentation
Canadian: Translational Models - Organoids - Gut on a chip		 Bruce Vallance, Vancouver
11:40 EST 2.3 Plenary Presentation
Canadian: Translational Models - Organoids - Gut on a chip		 Hagar Labouta, Toronto
12:00 EST 2.4 Expert Panel Discussion/Q&A
MODERATOR:  Heather Armstrong
PANEL:  Hagar Labouta, Phillipe Langella, Bruce Vallance
12:20 EST Lunch & Network Break (70 minutes)  

(3) Microbiome in IBD  Session Chair: Kathy McCoy
13:30 EST 3.1 Plenary Presentation
Canadian: Microbiome in IBD

Ben Willing, Edmonton
13:50 EST 3.2 Plenary Presentation
Canadian: Bioinformatics
Morgan Langille, Halifax
14:10 EST 3.3 Expert Panel Discussion/Q&A
MODERATOR: Kathy McCoy
PANEL:  Morgan Langille, Ben Willing
14:30 EST Refreshment & Network Break (15 mins)  


(4) Molecular Mechanisms of Disease Session Chair: Veronique Giroux
14:45 EST 4.1 Plenary Presentation
International: Immunology		 Emily Miraldi, Cincinnati
15:15 EST 4.2 Plenary Presentation
Canadian		 Paul Kubes, Calgary
15:35 EST 4.3 Expert Panel Discussion/Q&A MODERATOR:: Véronique Giroux
PANEL: Paul Kubes, Emily Miraldi
15:55 EST Open Group Discussion  
16:20 EST Closing Remarks and Program Evaluation CO-CHAIRS: Heather Armstrong & Jean-Eric Ghia
16:30 – 18:00 EST Meeting of the Minds Celebratory Reception Harbour Ballroom Foyer

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.